Biologic agents for treating rheumatoid arthritis. Concepts and progress
- 1 March 1997
- journal article
- review article
- Published by Wiley in Arthritis & Rheumatism
- Vol. 40 (3) , 397-409
- https://doi.org/10.1002/art.1780400302
Abstract
No abstract availableThis publication has 105 references indexed in Scilit:
- Adhesion Molecules — Blood Vessels and Blood CellsNew England Journal of Medicine, 1996
- THE THERAPEUTIC EFFECTS OF AN ENGINEERED HUMAN ANTI-TUMOUR NECROSIS FACTOR ALPHA ANTIBODY (CDP571) IN RHEUMATOID ARTHRITISRheumatology, 1995
- Dominant clonotypes in the repertoire of peripheral CD4+ T cells in rheumatoid arthritis.Journal of Clinical Investigation, 1994
- Antibody to the ligand of CD40, gp39, blocks the occurrence of the acute and chronic forms of graft-vs-host disease.Journal of Clinical Investigation, 1994
- The B7 and CD28 receptor familiesImmunology Today, 1994
- Chimeric cd4 monoclonal antibody cm‐t412 as a therapeutic approach to rheumatoid arthritisArthritis & Rheumatism, 1993
- Use of a chimeric monoclonal anti‐CD4 antibody in patients with refractory rheumatoid arthritisArthritis & Rheumatism, 1993
- Double‐blind trial of recombinant γ‐interferon versus placebo in the treatment of rheumatoid arthritisArthritis & Rheumatism, 1989
- Systemic administration of TIMP in the treatment of collagen-induced arthritis in miceInflammation Research, 1989
- Treatment with gamma‐interferon triggers the onset of collagen arthritis in miceArthritis & Rheumatism, 1988